Our study showed a correlation between the presence of AIDS and COVID-19 and an increased risk of D-VL, and among high levels of Nadir CD4+ T-cells, longer duration of therapy, higher prescriber’s perception of adherence, and a reduced risk of D-VL. The gene discussed is CD4; the disease is AIDS.